About Guerbet
Guerbet is a company based in Villepinte (France) founded in 1926. The company has 2,900 employees as of December 31, 2024. Guerbet offers products and services including Dotarem, Elucirem, OptiStar Elite, and OptiVantage. Guerbet operates in a competitive market with competitors including On Target Laboratories, Osprey Medical, RenalGuard Solutions, Cision Vision and Solstice Pharmaceuticals, among others.
- Headquarter Villepinte, France
- Employees 2900 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Guerbet Sa
-
Annual Revenue
$873.81 M (USD)7.05as on Dec 31, 2024
-
Net Profit
$16.71 M (USD)-32.61as on Dec 31, 2024
-
EBITDA
$108.16 M (USD)11.22as on Dec 31, 2024
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
2900
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Guerbet
Guerbet is a publicly listed company on the EURONEXT with ticker symbol GBT in France, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Guerbet
Guerbet offers a comprehensive portfolio of products and services, including Dotarem, Elucirem, OptiStar Elite, and OptiVantage.
Contrast agent used for enhancing MRI diagnostic imaging
Agent for magnetic resonance imaging procedures
Device for delivering contrast in MRI scans
Multi-use injector for CT contrast administration
People of Guerbet
Unlock access to complete
Unlock access to complete
Funding Insights of Guerbet
Detailed funding history for Guerbet
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Guerbet
Investment portfolio details for Guerbet
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Guerbet
Detailed financials for Guerbet
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Guerbet Comparisons
Peer comparison for Guerbet
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Guerbet
Guerbet operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as On Target Laboratories, Osprey Medical, RenalGuard Solutions, Cision Vision and Solstice Pharmaceuticals, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Molecular imaging agents for cancer surgery are developed.
|
|
| Locked | Locked | Locked |
Technology to reduce contrast dye exposure
|
|
| Locked | Locked | Locked |
Technologies for the cardiac and vascular markets
|
|
| Locked | Locked | Locked |
High contrast real-time imaging devices are developed for medical visualization.
|
|
| Locked | Locked | Locked |
Ultrasound contrast agents are developed for diagnosing multiple diseases.
|
Detailed competitors of Guerbet
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Guerbet
Complete news archive for Guerbet
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Guerbet
Guerbet was founded in 1926.
Guerbet is headquartered in Villepinte, France. It is registered at Villepinte, Ile-de-france, France.
As of Dec 31, 2024, the latest employee count at Guerbet is 2,900.
Annual revenue of Guerbet is $873.81M as on Dec 31, 2024.
Guerbet was founded in 1926 and is headquartered in Villepinte, France. Operations focus on the medical imaging sector, where contrast media and delivery systems are provided for CT scans, Cath Lab procedures, MRI examinations, interventional radiology, and theranostic applications. A range of medical devices is also supplied for angiography, scanners, and MRI setups, supporting diagnostic and therapeutic needs in healthcare settings.
Guerbet's top competitors include On Target Laboratories, Osprey Medical and RenalGuard Solutions.
Guerbet offers Dotarem, Elucirem, OptiStar Elite, and OptiVantage.
Yes, Guerbet is publicly traded on EURONEXT under the ticker symbol GBT.
The ticker symbol of Guerbet is GBT on EURONEXT.